Insider · CIK 0002125071
Keeren Rameshchandra Shah
Files at OKYO (OKYO Pharma Ltd). First filing -, latest -.
Keeren Rameshchandra Shah files SEC Form 4 as CFO at OKYO (OKYO Pharma Ltd). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Keeren Rameshchandra Shah has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 1 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 8, 2026 | OKYO OKYO Pharma Ltd | AGrant or award Optionderivative | +40,000 | $1.85 | $74k | 544,819 | Jun 10, 2026 |
Questions about Keeren Rameshchandra Shah
Answered from the filings on this page, as of the latest one.
Is Keeren Rameshchandra Shah buying or selling?
Keeren Rameshchandra Shah has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Keeren Rameshchandra Shah's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Keeren Rameshchandra Shah has 0.
Where does Keeren Rameshchandra Shah file Form 4?
Keeren Rameshchandra Shah has filed Form 4 at OKYO (OKYO Pharma Ltd) as Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.